Canine obesity - An overview

Journal of Veterinary Pharmacology and Therapeutics

Volumn 30, Issue SUPPL. 1, 2007, Pages 1-10

  Gossellin, J ^a   Wren, J A ^b   Sunderland, S J ^a  

^a PFIZER GLOBAL RESEARCH AND DEVELOPMENT   (United Kingdom)

^b PFIZER INC   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

(3 CHLOROPHENYL)PIPERAZINE; 2,4 DINITROPHENOL; AMPHETAMINE; AMPHETAMINE DERIVATIVE; AMYLASE INHIBITOR; CHLOROCITRIC ACID; CHORIONIC GONADOTROPIN; CLENBUTEROL; DEXFENFLURAMINE; DIRLOTAPIDE; EPHEDRA EXTRACT; EPHEDRINE; FENFLURAMINE; FLUOXETINE; GROWTH HORMONE; HYDROXYCITRIC ACID; MICROSOMAL TRIGLYCERIDE TRANSFER PROTEIN INHIBITOR; MITRATAPIDE; PHENTERMINE; PHENYLPROPANOLAMINE; SEROTONIN 2 AGONIST; SEROTONIN 6 ANTAGONIST; SIBUTRAMINE; SUCROSE POLYESTER; TETRAHYDROLIPSTATIN; THYROID HORMONE; UNCLASSIFIED DRUG;

ANOREXIA; ANXIETY DISORDER; APPETITE; BLOOD PRESSURE; BODY COMPOSITION; BODY TEMPERATURE; BODY WEIGHT; BONE MINERAL; BRADYCARDIA; CALORIC RESTRICTION; CARBOHYDRATE METABOLISM; DEATH; DIET; DOG; DRUG MEGADOSE; DUAL ENERGY X RAY ABSORPTIOMETRY; ENERGY ABSORPTION; EXERCISE; FLATULENCE; FOOD INTAKE; GASTROINTESTINAL MOTILITY; GLUCOSURIA; HEART PALPITATION; HUMAN; HYPERGLUCAGONEMIA; HYPERGLYCEMIA; HYPOINSULINEMIA; HYPOTHERMIA; INSOMNIA; INTESTINE MOTILITY; LIPIDOSIS; MENTAL DISEASE; NERVOUSNESS; NONHUMAN; OBESITY; PRIORITY JOURNAL; REVIEW; SATIETY; SIDE EFFECT; STEATORRHEA; STROKE; TACHYCARDIA; WEIGHT CONTROL; WEIGHT REDUCTION; XEROSTOMIA;

ANIMALS; DOG DISEASES; DOGS; OBESITY;

CANIS FAMILIARIS;

EID: 34249797876     PISSN: 01407783     EISSN: 13652885     Source Type: Journal    
DOI: 10.1111/j.1365-2885.2007.00863.x     Document Type: Review

References (100)

1. Acharya, N.V., Wilton, L.V. Shakir, S.A. (2006) Safety profile of orlistat: results of a prescription-event monitoring study. International Journal of Obesity (London), 30, 1645 1652.
2. Anon (1999) Freedom of Information Summary. Xenical (Orlistat) Capsules. Hoffmann-La Roche. NDA 99/020766A. Application Number 20-766. Approval date 4/23/1999 US Food & Drug Administration Center for Drug Evaluation and Research. Available at: http://www.fda.gov/cder/foi/nda/99/020766a.htm accessed 15 March 2007.
3. Anon (2006) Yarvitan. Summary of Product Characteristics. Janssen Animal Health, B-2340 Beerse, Belgium. Available at: http://www.emea.europa.eu/vetdocs/ PDFs/EPAR/yarvitan/yarvitan-V-113-00-00-P1-en.pdf accessed on 10 March 2007.
4. Ballinger, A. Peikin, S.R. (2002) Orlistat: its current status as an anti-obesity drug. European Journal of Pharmacology, 440, 109 117.
5. Batterham, R.L., Cowley, M.A., Small, C.J., Herzog, H., Cohen, M.A., Dakin, C.L., Wren, A.M., Brynes, A.E., Low, M.J., Ghatei, M.A., Cone, R.D. Bloom, S.R. (2002) Gut hormone PYY3-36 physiologically inhibits food intake. Nature, 418, 650 654.
6. Batterham, R.L., Cohen, M.A., Ellis, S.M., Le Roux, C.W., Withers, D.J., Frost, G.S., Ghatei, M.A. Bloom, S.R. (2003a) Inhibition of food intake in obese subjects by peptide YY3-36. New England Journal of Medicine, 349, 941 948.
7. Batterham, R.L., Le Roux, C.W., Cohen, M.A., Park, A.J., Ellis, S.M., Patterson, M., Frost, G.S., Ghatei, M.A. Bloom, S.R. (2003b) Pancreatic polypeptide reduces appetite and food intake in humans. The Journal of Clinical Endocrinology and Metabolism, 88, 3989 3992.
8. Bickerdike, M.J. (2003) 5-HT2C receptor agonists as potential drugs for the treatment of obesity. Current Topics in Medicinal Chemistry, 3, 885 897.
9. Bierer, T.L. Bui, L.M. (2004) High-protein low-carbohydrate diets enhance weight loss in dogs. Journal of Nutrition, 134, 2087S 2089S.
10. Bosakowski, T. Levin, A.A. (1987) Comparative acute toxicity of chlorocitrate and fluorocitrate in dogs. Toxicology and Applied Pharmacology, 89, 97 104.
11. Burkholder, W.J. (2001) Precision and practicality of methods of assessing body composition of dogs and cats. Compendium on Continuing Education for the Practicing Veterinarian, 23 (Suppl. A 1 10.
12. Burkholder, W.J. Bauer, J.E. (1998) Foods and techniques for managing obesity in companion animals. Journal of the American Veterinary Medical Association, 212, 658 662.
13. Burkholder, W.J. Thatcher, C.D. (1998) Validation of predictive equations for use of deuterium oxide dilution to determine body composition of dogs. American Journal of Veterinary Research, 59, 927 937.
14. Burkholder, W.J., Taylor, L. Hulse, D.A. (2000) Weight loss to optimal body condition increases ground reactive force in dogs with osteoarthritis. Proceedings. 2000 Purina Nutritional Forum. Research Abstracts, p. 74.
15. Butterwick, R. (2001) Considerations for weight-reduction programs. The Compendium on Continuing Education for the Practicing Veterinarian, 23, 43 44.
16. Butterwick, R.F. Hawthorne, A.J. (1998) Advances in dietary management of obesity in dogs and cats. Journal of Nutrition, 128, 2771S 2775S.
17. Carlson, G.L., Li, B.U., Bass, P. Olsen, W.A. (1983) A bean alpha-amylase inhibitor formulation (starch blocker) is ineffective in man. Science, 219, 393 395.
18. Center, S.A., Harte, J., Watrous, D., Reynolds, A., Watson, T.D.G., Markwell, P.J., Millington, D.S., Wood, P.A., Yeager, A.E. Erb, H.N. (2000) The clinical and metabolic effects of rapid weight loss in obese pet cats and the influence of supplemental oral L-carnitine. Journal of Veterinary Internal Medicine, 14, 598 608.
19. Chelikani, P.K., Haver, A.C., Reeve, J.R., Keire, D.A. Reidelberger, R.D. (2006) Daily, intermittent intravenous infusion of peptide YY (3-36) reduces daily food intake and adiposity in rats. American Journal of Physiology - Regulatory, Integrative and Comparative Physiology, 290, R298 R305.
20. Cohen, M.A., Ellis, S.M., Le Roux, C.W., Batterham, R.L., Park, A., Patterson, M., Frost, G.S., Ghatei, M.A. Bloom, S.R. (2003) Oxyntomodulin suppresses appetite and reduces food intake in humans. The Journal of Clinical Endocrinology and Metabolism, 88, 4696 4701.
21. Crane, S.W. (1991) Occurrence and management of obesity in companion animals. Journal of Small Animal Practice, 32, 275 282.
22. De Graaf, C., Hulshof, T., Weststrate, J.A. Hautvast, J.G. (1996) Nonabsorbable fat (sucrose polyester) and the regulation of energy intake and body weight. American Journal of Physiology - Regulatory, Integrative and Comparative Physiology, 270, R1386 R1393.
23. Diez, M., Nguyen, P., Jeusette, I., Devois, C., Istasse, L. Biourge, V. (2002) Weight loss in obese dogs: evaluation of a high-protein, low-carbohydrate diet. Journal of Nutrition, 132, 1685S 1687S.
24. Druce, M.R., Small, C.J. Bloom, S.R. (2004) Minireview: gut peptides regulating satiety. Endocrinology, 145, 2660 2665.
25. Dulloo, A.G. Miller, D.S. (1984) Thermogenic drugs for the treatment of obesity: sympathetic stimulants in animal models. British Journal of Nutrition, 52, 179 196.
26. Dyck, D.J. (2000) Dietary fat intake, supplements, and weight loss. Canadian Journal of Applied Physiology, 25, 495 523.
27. Edney, A.T.B. Smith, P.M. (1986) Study of obesity in dogs visiting veterinary practices in the United Kingdom. Veterinary Record, 118, 391 396.
28. Fekete, S., Hullár, I., Andrásofszky, E., Rigó, Z. Berkényi, T. (2001) Reduction of the energy density of cat foods by increasing their fibre content with a view to nutrient's digestibility. Journal of Animal Physiology and Animal Nutrition, 85, 200 204.
29. Fettman, M.J., Stanton, C.A., Banks, L.L., Hamar, D.W., Johnson, D.E., Hegstad, R.L. Johnston, S. (1997) Effects of neutering on body rate, metabolic rate and glucose tolerance in domestic cats. Research in Veterinary Science, 62, 131 136.
30. Fitzgerald, L.W., Burn, T.C., Brown, B.S., Patterson, J.P., Corjay, M.H., Valentine, P.A., Sun, J.H., Link, J.R., Abbaszade, I., Hollis, J.M., Largent, B.L., Hartig, P.R., Hollis, G.F., Meunier, P.C., Robichaud, A.J. Robertson, D.W. (2000) Possible role of valvular serotonin 5-HT(2B) receptors in the cardiopathy associated with fenfluramine. Molecular Pharmacology, 57, 75 81.
31. Freeman, L.M., Kehayias, J.J. Roubenoff, R. (1996) Letter to the editor. Journal of Veterinary Internal Medicine, 10, 99 100.
32. Gentry, S.J. (1993) Results of the clinical use of a standardized weight-reduction program in dogs and cats. Journal of the American Animal Hospital Association, 29, 369 375.
33. German, A.J. (2006) The growing problem of obesity in dogs and cats. Journal of Nutrition, 136, 1940S 1946S.
34. Glickman, L.T., Sonnenschein, E., Glickman, N.W., Donoghue, S. Goldschmidt, M.H. (1995) Patterns of diet and obesity in female adult pet dogs. Veterinary Clinical Nutrition, 1, 6 13.
35. Goldstein, D.J., Rampey, A.H., Dornseif, B.E., Levine, L.R., Potvin, J.H. Fludzinski, L.A. (1993) Fluoxetine: a randomized clinical trial in the maintenance of weight loss. Obesity Research, 1, 92 98.
36. Goldstein, D.J., Rampey, A.H., Enas, G.G., Potvin, J.H., Fludzinski, L.A. Levine, L.R. 1994) Fluoxetine: a randomized clinical trial in the treatment of obesity. International Journal of Obesity and Related Metabolic Disorders, 18, 129 135.
37. Graham, P.A., Maskell, I.E., Rawlings, J.M., Nash, A.S. Markwell, P.J. (2002) Influence of a high fibre diet on glycaemic control and quality of life in dogs with diabetes mellitus. Journal of Small Animal Practice, 43, 67 73.
38. Grover, G.J., Mellström, K., Ye, L., Malm, J., Li, Y.-L., Bladh, L.-G., Sleph, P.G., Smith, M.A., George, R., Vennström, B., Mookhtiar, K., Horvath, R., Speelman, J., Egan, D. Baxter, J.D. (2003) Selective thyroid hormone receptor-beta activation: a strategy for reduction of weight, cholesterol, and lipoprotein (a) with reduced cardiovascular liability. Proceedings of the National Academy of Sciences of the United States of America, 100, 10067 10072.
39. Hainer, V., Kabrnova, K., Aldhoon, B., Kunesova, M. Wagenknecht, M. (2006) Serotonin and norepinephrine reuptake inhibition and eating behaviour. Annals of the New York Academy of Sciences, 1083, 252 269.
40. Halford, J.C., Harrold, J.A., Boyland, E.J., Lawton, C.L. Blundell, J.E. (2007) Serotonergic drugs: effects on appetite suppression and use for the treatment of obesity. Drugs, 67, 27 55.
41. Hand, M.S., Armstrong, P.J. Allen, T.A. (1989) Obesity: occurrence, treatment, and prevention. Veterinary Clinics of North America: Small Animal Practice, 19, 447 474.
42. Harper, J.A., Dickinson, K. Brand, M.D. (2001) Mitochondrial uncoupling as a target for drug development in the treatment of obesity. Obesity Reviews, 2, 255 265.
43. Heshka, S., Nauss-Karol, C., Nyman, A., Reisen, K., Kissileff, H.R., Porikos, K.P. Kral, J.G. (1985) Effects of chlorocitrate on body weight in obese men on a metabolic ward. Nutrition and Behavior, 2, 233 246.
44. Hollenbeck, C.B., Coulston, A.M., Quan, R., Becker, T.R., Vreman, H.J., Stevenson, D.K. Reaven, G.M. (1983) Effects of a commercial starch blocker preparation on carbohydrate digestion and absorption: in vivo and in vitro studies. American Journal of Clinical Nutrition, 38, 498 503.
45. Horner, W.D. (1941) A study of dinitrophenol and its relation to cataract formation. Transactions of the American Ophthalmological Society, 39, 405 437.
46. Impellizeri, J.A., Tetrick, M.A. Muir, P. (2000) Effect of weight reduction on clinical signs of lameness in dogs with hip osteoarthritis. Journal of the American Veterinary Medical Association, 216, 1089 1091.
47. Jeusette, I., Detilleux, J., Cuvelier, C., Istasse, L. Diez, M. (2004) Ad libitum feeding following ovariectomy in female Beagle dogs: Effect on maintenance energy requirement and on blood metabolites. Journal of Animal Physiology and Animal Nutrition, 88, 117 121.
48. Jewell, D.E. Toll, P.W. (1996) Effects of fibre on food intake. Veterinary Clinical Nutrition, 3, 115 118.
49. Jewell, D.E., Toll, P.W. Novotny, B.J. (2000) Satiety reduces adiposity in dogs. Veterinary Therapeutics, 1, 17 23.
50. Kelly, S.M. Hunter, J.O. (1996) The effect of a non-absorbable fat substitute, sucrose polyester, on gastrointestinal function. Alimentary Pharmacology and Therapeutics, 10, 715 720.
51. Kienzle, E., Bergler, R. Mandernach, A. (1998) A comparison of the feeding behaviour and the human-animal relationship in owners of normal and obese dogs. Journal of Nutrition, 128, 2779S 2782S.
52. Kirk, C.A., Boucher, J.F., Sunderland, S.J. Wren, J.A. (2007) Influence of dirlotapide, a microsomal triglyceride transfer protein inhibitor, on the digestibility of a dry expanded diet in adult dogs. Journal of Veterinary Pharmacology and Therapeutics, 30 (Suppl. 1), 66 72.
53. Kronfeld, D.S., Donoghue, S. Glickman, L.T. (1991) Body condition and energy intakes of dogs in a referral teaching hospital. Journal of Nutrition, 121, 157 158.
54. Kuruvilla, A. Frankel, T.L. (2003) Heart rate of pet dogs: effects of overweight and exercise. Asia Pacific Journal of Clinical Nutrition, 12, S51.
55. Kushner, R.F. Manzano, H. (2002) Obesity pharmacology: past, present, and future. Current Opinion in Gastroenterology, 18, 213 220.
56. Laflamme, D. (1997) Development and validation of a body condition score system for dogs. Canine Practice, 22, 10 15.
57. Laflamme, D.P. (2001) Challenges with weight-reduction studies. The Compendium on Continuing Education for the Practicing Veterinarian, 23, 45 50.
58. Laflamme, D.P. Kuhlman, G. (1995) The effect of weight loss regimen on subsequent weight maintenance in dogs. Nutrition Research, 15, 1019 1028.
59. Laflamme, D.P., Kuhlman, G., Lawler, D.F., Kealy, R.D. Schmidt, D.A. (1994) Obesity management in dogs. Veterinary Clinical Nutrition, 1, 59 65.
60. Laflamme, D.P., Kuhlman, G. Lawler, D.F. (1997) Evaluation of weight loss protocols for dogs. Journal of the American Animal Hospital Association, 33, 253 259.
61. Lauten, S.D., Cox, N.R., Brawner, W.R. Baker, H.J. (2001) Use of dual-energy x-ray absorptiometry for non-invasive body composition measurements in clinically normal dogs. American Journal of Veterinary Research, 62, 1295 1301.
62. Layer, P., Carlson, G.L. DiMagno, E.P. (1985) Partially purified white bean amylase inhibitor reduces starch digestion in vitro and inactivates intraduodenal amylase in humans. Gastroenterology, 88, 1895 1902.
63. Leibowitz, S.F. Hor, L. (1983) Endorphinergic and α-noradrenergic systems in the paraventricular nucleus: effects on eating behavior. Peptides, 3, 421 428.
64. Leibowitz, S.F. Wortley, K.E. (2004) Hypothalamic control of energy balance: different peptides, different functions. Peptides, 25, 473 504.
65. Lewis, L.D., Morris, M.L. Hand, M.S. (1987) Small Animal Clinical Nutrition III, 3rd edn. Mark Morris Associates, Topeka, KS, pp. 6.2 6.39.
66. Lin, H.C., Neevel, C. Chen, J.H. (2004) Slowing intestinal transit by PYY depends on serotonergic and opioid pathways. American Journal of Physiology - Gastrointestinal and Liver Physiology, 286, G558 G563.
67. Luque, C.A. Rey, J.A. (2002) The discovery and status of sibutramine as an anti-obesity drug. European Journal of Pharmacology, 440, 119 128.
68. Markwell, P.J., Butterwick, R.F., Wills, J.M. Raiha, M. (1994) Clinical studies in the management of obesity in dogs and cats. International Journal of Obesity, 18, S39 S43.
69. Martin, L.J., Siliart, B., Dumon, H.J. Nguyen, P.G. (2006) Hormonal disturbances associated with obesity in dogs. Journal of Animal Physiology and Animal Nutrition, 90, 355 360.
70. Mason, E. (1970) Obesity in pet dogs. Veterinary Record, 86, 612 616.
71. Mawby, D.I., Bartges, J.W., D'Avignon, A., Laflamme, D.P., Moyers, T.D. Cottrell, T. (2004) Comparison of various methods for estimating body fat in dogs. Journal of the American Animal Hospital Association, 40, 109 114.
72. Mcgreevy, P.D., Thompson, P.C., Pride, C., Fawcett, A., Grassi, T. Jones, B. (2005) Prevalence of obesity in dogs examined by Australian veterinary practices and the risk factors involved. Veterinary Record, 156, 695 702.
73. Meyer, H., Drochner, W. Weidenhaupt, C. (1978) Ein Beitrag zum Vorkommen und zur Behandlung der Adipositas des Hundes. Deutsche Tierärztliche Wochenschrift, 85, 133 136.
74. Munday, H.S., Booles, D., Anderson, P., Poore, D.W. Earle, K.E. (1994) The repeatability of body composition measurements in dogs and cats using dual energy X-ray absorptiometry. Journal of Nutrition, 124, 2619S 2621S.
75. Nonogaki, K., Ohashi-Nozue, K. Oka, Y. (2006) A negative feedback system between brain serotonin systems and plasma active ghrelin levels in mice. Biochemical and Biophysical Research Communications, 341, 703 707.
76. Pilichiewicz, A.N., Little, T.J., Brennan, I.M., Meyer, J.H., Wishart, J.M., Otto, B., Horowitz, M. Feinle-Bisset, C. (2005) Effects of load, and duration, of duodenal lipid on antropyloroduodenal motility, plasma CCK and PYY, and energy intake in healthy men. American Journal of Physiology - Regulatory, Integrative and Comparative Physiology, 290, R668 R677.
77. Remillard, R.L. (2001) Clinical aspects of obesity management. The Compendium on Continuing Education for the Practicing Veterinarian, 23, 29 32.
78. Robertson, I.D. (2003) The association of exercise, diet and other factors with owner-perceived obesity in privately owned dogs from metropolitan Perth, WA. Preventative Veterinary Medicine, 58, 75 83.
79. Rothman, R.B. Baumann, M.H. (2002) Serotonin releasing agents. Neurochemical, therapeutic and adverse effects. Pharmacology, Biochemistry, and Behavior, 71, 825 836.
80. Samanin, R. Garattini, S. (1993) Neurochemical mechanism of action of anorectic drugs. Pharmacology and Toxicology, 73, 63 68.
81. Schwartz, M.W., Woods, S.C., Porte, D., Seeley, R.J. Baskin, D.G. (2000) Central nervous system control of food intake. Nature, 404, 661 671.
82. Seagle, H.M., Bessesen, D.H. Hill, J.O. (1998) Effects of sibutramine on resting metabolic rate and weight loss in overweight women. Obesity Research, 6, 115 121.
83. Shara, M., Ohia, S.E., Schmidt, R.E., Yasmin, T., Zardetto-Smith, A., Kincaid, A., Bagchi, M., Chatterjee, A., Bagchi, D. Stohs, S.J. (2004) Physico-chemical properties of a novel (-)-hydrocitric acid extract and its effect on body weight, selected organ weights, hepatic lipid peroxidation and DNA fragmentation, hematology and clinical chemistry, and histopathological changes over a period of 90 days. Molecular and Cellular Biochemistry, 260, 171 186.
84. Shekelle, P.G., Hardy, M.L., Morton, S.C., Maglione, M., Mojica, W.A., Suttorp, M.J., Rhodes, S.L., Jungvig, L. Gagne, J. (2003) Efficacy and safety of ephedra and ephedrine for weight loss and athletic performance: a meta-analysis. Journal of the American Medical Association, 289, 1537 1545.
85. Sibley, K.W. (1984) Diagnosis and management of the overweight dog. British Veterinary Journal, 140, 124 131.
86. Simpson, J.W., Anderson, R.S. Markwell, P.J. (1993) Clinical Nutrition of Dog and Cat. Blackwell Scientific, Oxford, UK, pp. 56 95.
87. Sloth, C. (1992) Practical management of obesity in dogs and cats. Journal of Small Animal Practice, 33, 178 182.
88. Smith, G.P., Gibbs, J., Jerome, C., Pi-Sunyer, F.X., Kissileff, H.R. Thornton, J. (1981) The satiety effect of cholecystokinin: a progress report. Peptides, 2, 57 59.
89. Smith, B.M., Thomsen, W.J. Grottick, A.J. (2006) The potential use of selective 5-HT2C agonists in treating obesity. Expert Opinion on Investigational Drugs, 15, 257 266.
90. Son, H.R., d'Avignon, A. Laflamme, D.P. (1998) Comparison of dual-energy X-ray absorptiometry and measurement of total body water content by deuterium oxide dilution for estimating body composition in dogs. American Journal of Veterinary Research, 59, 529 532.
91. Speakman, J.R., Booles, D. Butterwick, R. (2001) Validation of dual-energy X-ray absorptiometry (DXA) by comparison with chemical analysis of dogs and cats. International Journal of Obesity, 25, 439 447.
92. Stanley, S., Wynne, K. Bloom, S. (2004) Gastrointestinal satiety signals III. Glucagon-like peptide 1, oxyntomodulin, peptide YY, and pancreatic polypeptide. American Journal of Physiology - Gastrointestinal and Liver Physiology, 286, G693 G697.
93. Sunvold, G.D., Fahey, G.C., Merchen, N.R., Bauer, L.L. Reinhart, G.A. (1995) Evaluation of nutrient digestibility and faecal characteristics of cats fed diets containing selected fiber sources and their blends. American College of Veterinary Internal Medicine Abstracts. Journal of Veterinary Internal Medicine, 9, 214.
94. Thomson, A.B., Hunt, R.H. Zorich, N.L. (1998) Review article: olestra and its gastrointestinal safety. Alimentary Pharmacology and Therapeutics, 12, 1185 1200.
95. Vickers, S.P., Dourish, C.T. Kennett, G.A. (2001) Evidence that hypophagia induced by d-fenfluramine and d-norfenfluramine in the rat is mediated by 5-HT2C receptors. Neuropharmacology, 41, 200 209.
96. Weatherford, S.C., Salabarria, J., Nelson, D. Laughton, W.B. (1991) (-)threo-chlorocitric acid decreases sham feeding of sucrose in rats. Pharmacology, Biochemistry and Behavior, 40, 75 78.
97. Woods, S.C. (2004) Gastrointestinal satiety signals I. An overview of gastrointestinal signals that influence food intake. American Journal of Physiology - Gastrointestinal and Liver Physiology, 286, G7 G13.
98. Wren, J.A., Gossellin, J. Sunderland, S.J. (2007) Dirlotapide: a review of its properties and role in the management of obesity in dogs. Journal of Veterinary Pharmacology and Therapeutics, 30 (Suppl. 1), 11 16.
99. Wynne, K., Stanley, S. Bloom, S. (2004) The gut and regulation of body weight. Journal of Clinical Endocrinology and Metabolism, 89, 2576 2582.
100. Yoshikawa, H., Kotaru, M., Tanaka, C., Ikeuchi, T. Kawabata, M. (1999) Characterization of kintoki bean (Phaseolus vulgaris) alpha-amylase inhibitor: inhibitory activities against human salivary and porcine pancreatic alpha-amylases and activity changes by proteolytic digestion. Journal of Nutritional Science and Vitaminology (Tokyo), 45, 797 802.